银屑病关节炎的流行病学
The Epidemiology of Psoriatic Arthritis.
作者信息
Ogdie Alexis, Weiss Pamela
机构信息
Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, White Building, Room 5024, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Division of Rheumatology, Children's Hospital of Philadelphia, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, 3535 Market Street, Room 1526, Philadelphia, PA 19104, USA.
出版信息
Rheum Dis Clin North Am. 2015 Nov;41(4):545-68. doi: 10.1016/j.rdc.2015.07.001. Epub 2015 Sep 11.
Abstract
Psoriatic arthritis (PsA) is a chronic systemic inflammatory disorder characterized by joint and entheseal inflammation with a prevalence of 0.05% to 0.25% of the population and 6% to 41% of patients with psoriasis. PsA is a highly heterogeneous inflammatory arthritis. In this review, current knowledge is discussed regarding the epidemiology of PsA, including disease manifestations, classification criteria for adult and juvenile PsA, methods for recognizing early PsA, including use of screening tools and knowledge of risk factors for PsA, and medical comorbidities associated with PsA.
摘要
银屑病关节炎（PsA）是一种慢性全身性炎症性疾病，其特征为关节和附着点炎症，在人群中的患病率为0.05%至0.25%，在银屑病患者中的患病率为6%至41%。PsA是一种高度异质性的炎性关节炎。在本综述中，我们讨论了关于PsA流行病学的现有知识，包括疾病表现、成人和青少年PsA的分类标准、识别早期PsA的方法（包括筛查工具的使用和PsA危险因素的知识）以及与PsA相关的合并症。
相似文献
1
The Epidemiology of Psoriatic Arthritis.
Rheum Dis Clin North Am. 2015 Nov;41(4):545-68. doi: 10.1016/j.rdc.2015.07.001. Epub 2015 Sep 11.
2
Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis.
Arthritis Care Res (Hoboken). 2011 Dec;63(12):1729-35. doi: 10.1002/acr.20627.
3
Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies.
J Autoimmun. 2017 Jan;76:21-37. doi: 10.1016/j.jaut.2016.10.009. Epub 2016 Nov 9.
4
Comorbidities in Psoriatic Arthritis.
Rheum Dis Clin North Am. 2015 Nov;41(4):677-98. doi: 10.1016/j.rdc.2015.07.008. Epub 2015 Sep 5.
5
Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey.
J Eur Acad Dermatol Venereol. 2009 Jun;23(6):683-91. doi: 10.1111/j.1468-3083.2009.03159.x. Epub 2009 Mar 6.
6
Prevalence and clinical features of psoriatic arthritis in psoriasis patients in Spain. Limitations of PASE as a screening tool.
Eur J Dermatol. 2015 Jan-Feb;25(1):57-63. doi: 10.1684/ejd.2014.2449.
7
Psoriasis and systemic inflammation: underdiagnosed enthesopathy.
J Eur Acad Dermatol Venereol. 2009 Sep;23 Suppl 1:3-8. doi: 10.1111/j.1468-3083.2009.03361.x.
8
Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics.
J Am Acad Dermatol. 2014 Oct;71(4):649-55. doi: 10.1016/j.jaad.2014.05.010. Epub 2014 Jun 25.
9
Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis.
Int J Rheum Dis. 2015 Nov;18(8):873-9. doi: 10.1111/1756-185X.12580. Epub 2015 Jul 14.
10
Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis?
G Ital Dermatol Venereol. 2014 Apr;149(2):177-84.
引用本文的文献
1
Psoriatic arthritis incidence and prevalence trajectory in Poland-public-payer, national-level, long-term data.
Rheumatol Int. 2025 Sep 2;45(9):212. doi: 10.1007/s00296-025-05966-5.
2
Targeting dendritic cell-specific TNFR2 improves skin and joint inflammation in a murine model of psoriatic arthritis.
Sci Rep. 2025 Aug 27;15(1):31574. doi: 10.1038/s41598-025-15175-6.
3
Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies.
RMD Open. 2025 Aug 25;11(3):e005522. doi: 10.1136/rmdopen-2025-005522.
4
Beyond inflammation: the molecular basis of bone remodeling in axial spondyloarthritis and psoriatic arthritis.
Front Immunol. 2025 Jul 31;16:1599995. doi: 10.3389/fimmu.2025.1599995. eCollection 2025.
5
Diagnostic accuracy of machine learning approaches to identify psoriatic arthritis: a meta-analysis.
Clin Exp Med. 2025 Aug 9;25(1):284. doi: 10.1007/s10238-025-01734-8.
6
Psoriatic arthritis in transition: cytokine signaling, immune dysregulation, and therapeutic innovation.
Inflammopharmacology. 2025 Jul 25. doi: 10.1007/s10787-025-01865-0.
7
Estimating the incidence of autoimmune inflammatory arthritis after Lyme disease.
Semin Arthritis Rheum. 2025 Jul 16;74:152797. doi: 10.1016/j.semarthrit.2025.152797.
8
Angiopoietins: multifaceted mediators in the pathogenesis of joint-related disorders.
Histochem Cell Biol. 2025 Jun 20;163(1):68. doi: 10.1007/s00418-025-02395-0.
9
Distribution of Arthritis Subtypes Among Adults With Arthritis in the United States, 2017-March 2020.
Prev Chronic Dis. 2025 Jun 19;22:E28. doi: 10.5888/pcd22.240393.
10
Are Systemic Drug Choices for Psoriasis by Dermatologists Compatible with Psoriatic Arthritis? Data from the German National Psoriasis Registry PsoBest.
Psoriasis (Auckl). 2025 May 30;15:197-207. doi: 10.2147/PTT.S524083. eCollection 2025.
本文引用的文献
1
Distinctions between diagnostic and classification criteria?
Arthritis Care Res (Hoboken). 2015 Jul;67(7):891-7. doi: 10.1002/acr.22583.
2
Enthesitis as a component of dactylitis in psoriatic juvenile idiopathic arthritis: histology of an established clinical entity.
Pediatr Rheumatol Online J. 2015 Feb 28;13:7. doi: 10.1186/s12969-015-0003-2. eCollection 2015.
3
Recognizing and managing comorbidities in psoriatic arthritis.
Curr Opin Rheumatol. 2015 Mar;27(2):118-26. doi: 10.1097/BOR.0000000000000152.
4
Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial.
Clin Exp Rheumatol. 2015 Jan-Feb;33(1):11-9. Epub 2014 Dec 22.
5
Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study.
Ann Rheum Dis. 2015 Feb;74(2):326-32. doi: 10.1136/annrheumdis-2014-205675. Epub 2014 Oct 28.
6
Description of active joint count trajectories in juvenile idiopathic arthritis.
J Rheumatol. 2014 Dec;41(12):2466-73. doi: 10.3899/jrheum.130835. Epub 2014 Oct 1.
7
Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics.
J Am Acad Dermatol. 2014 Oct;71(4):649-55. doi: 10.1016/j.jaad.2014.05.010. Epub 2014 Jun 25.
8
Female sex and oligoarthritis category are not risk factors for uveitis in Italian children with juvenile idiopathic arthritis.
J Rheumatol. 2014 Jul;41(7):1416-25. doi: 10.3899/jrheum.131494. Epub 2014 Jun 15.
9
High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease.
J Rheumatol. 2014 Jul;41(7):1357-65. doi: 10.3899/jrheum.140021. Epub 2014 Jun 15.
10
Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden--a population-based register study.
PLoS One. 2014 May 29;9(5):e98024. doi: 10.1371/journal.pone.0098024. eCollection 2014.
Zotero 插件